169 related articles for article (PubMed ID: 15533726)
1. Relationship between insulin resistance and end-organ damage in white coat hypertension.
Tunçkale A; Aran SN; Karpuz H; Dirican A
Am J Hypertens; 2004 Nov; 17(11 Pt 1):1011-6. PubMed ID: 15533726
[TBL] [Abstract][Full Text] [Related]
2. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index.
Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J
Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte DNA damage and total antioxidant status in patients with white-coat hypertension and sustained hypertension.
Yildiz A; Gür M; Yilmaz R; Demirbağ R; Celik H; Aslan M; Koçyiğit A
Turk Kardiyol Dern Ars; 2008 Jun; 36(4):231-8. PubMed ID: 18765966
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin, insulin resistance, and left ventricular structure in dipper and nondipper essential hypertensive patients.
Della Mea P; Lupia M; Bandolin V; Guzzon S; Sonino N; Vettor R; Fallo F
Am J Hypertens; 2005 Jan; 18(1):30-5. PubMed ID: 15691614
[TBL] [Abstract][Full Text] [Related]
5. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension.
Stergiou GS; Argyraki KK; Moyssakis I; Mastorantonakis SE; Achimastos AD; Karamanos VG; Roussias LG
Am J Hypertens; 2007 Jun; 20(6):616-21. PubMed ID: 17531917
[TBL] [Abstract][Full Text] [Related]
6. End-organ damage in treated severe hypertension: close relation to nocturnal blood pressure.
Fagher B; Valind S; Thulin T
J Hum Hypertens; 1995 Aug; 9(8):605-10. PubMed ID: 8523373
[TBL] [Abstract][Full Text] [Related]
7. Nocturnal blood pressure fall and metabolic syndrome score in patients with white coat hypertension.
Vyssoulis G; Karpanou E; Adamopoulos D; Kyvelou SM; Gymnopoulou E; Cokkinos D; Stefanadis C
Blood Press Monit; 2008 Oct; 13(5):251-6. PubMed ID: 18799949
[TBL] [Abstract][Full Text] [Related]
8. [White-coat hypertension and risk factors in recently diagnosed hypertensive patients].
Aguirre-Ramos R; Trujillo-Hernández B; Huerta M; Trujillo X; Vásquez C; Millán-Guerrero RO
Gac Med Mex; 2002; 138(4):319-24. PubMed ID: 12200876
[TBL] [Abstract][Full Text] [Related]
9. Role of aldosterone in left ventricular hypertrophy in hypertension.
Matsumura K; Fujii K; Oniki H; Oka M; Iida M
Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
[TBL] [Abstract][Full Text] [Related]
10. End-organ damage in essential hypertension in the elderly.
Kohara K; Hiwada K
J Hum Hypertens; 1995 Sep; 9(9):717-21. PubMed ID: 8551484
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical correlates of white coat hypertension in chronic kidney disease.
Minutolo R; Borrelli S; Scigliano R; Bellizzi V; Chiodini P; Cianciaruso B; Nappi F; Zamboli P; Conte G; De Nicola L
Nephrol Dial Transplant; 2007 Aug; 22(8):2217-23. PubMed ID: 17420167
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance and blood pressure circadian variation in an obese hypertensive population.
Diamantopoulos EJ; Andreadis E; Tsourous G; Katsanou P; Georgiopoulos D; Fotia M; Antoniou A; Raptis SA
Clin Exp Hypertens; 2006 Oct; 28(7):625-30. PubMed ID: 17060061
[TBL] [Abstract][Full Text] [Related]
13. Low frequency of target organ damage in Taiwanese with white coat hypertension.
Tseng YZ; Chiang FT; Hsu KL; Lo HM; Tseng CD; Lin JL; Hwang JJ; Lai LP
J Formos Med Assoc; 2005 May; 104(5):327-32. PubMed ID: 15959599
[TBL] [Abstract][Full Text] [Related]
14. Glucose metabolism in patients with essential hypertension.
García-Puig J; Ruilope LM; Luque M; Fernández J; Ortega R; Dal-Ré R;
Am J Med; 2006 Apr; 119(4):318-26. PubMed ID: 16564774
[TBL] [Abstract][Full Text] [Related]
15. Are metabolic risk factors and target organ damage more frequent in masked hypertension than in white coat hypertension?
Yoon HJ; Ahn Y; Park JB; Park CG; Youn HJ; Choi DJ; Shin JH; Kim DW; Rim SJ; Bae JH;
Clin Exp Hypertens; 2010; 32(7):480-5. PubMed ID: 21029014
[TBL] [Abstract][Full Text] [Related]
16. Proportion of isolated clinical hypertension in primary care settings. Comparison of target organ damage in patients with isolated clinical hypertension and patients with sustained arterial hypertension.
Boreu QF; de Tuero GC; Rodríguez-Poncelas A; Albertos MS; Zafra MS; Radó MA;
Blood Press; 2007; 16(6):354-61. PubMed ID: 17852096
[TBL] [Abstract][Full Text] [Related]
17. A study of the influence of insulin resistance on left ventricular mass in hypertensive patients.
Kothari K; Devpura G; Sharma A; Hussain N
J Assoc Physicians India; 2000 Mar; 48(3):279-83. PubMed ID: 11229109
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome in subjects with white-coat hypertension: impact on left ventricular structure and function.
Mulè G; Nardi E; Cottone S; Cusimano P; Incalcaterra F; Palermo A; Giandalia M; Geraci C; Buscemi S; Cerasola G
J Hum Hypertens; 2007 Nov; 21(11):854-60. PubMed ID: 17541385
[TBL] [Abstract][Full Text] [Related]
19. True resistant hypertension: is it possible to be recognized in the office?
Muxfeldt ES; Bloch KV; Nogueira Ada R; Salles GF
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1534-40. PubMed ID: 16364821
[TBL] [Abstract][Full Text] [Related]
20. Effects of angiotensin-converting enzyme gene polymorphism and serum vitamin D levels on ambulatory blood pressure measurement and left ventricular mass in Turkish hypertensive population.
Kulah E; Dursun A; Aktunc E; Acikgoz S; Aydin M; Can M; Dursun A
Blood Press Monit; 2007 Aug; 12(4):207-13. PubMed ID: 17625392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
